Your browser doesn't support javascript.
A Case Series of SARS-CoV-2 Omicron Variant in Patients With Acute Leukemia.
Ali, Elrazi A; Alamin, Mohammed A; Abu-Tineh, Mohammad; Ahmed, Khalid; Alshurafa, Awni; Rozi, Waail; Yassin, Mohamed A.
  • Ali EA; Internal Medicine, Hamad Medical Corporation, Doha, QAT.
  • Alamin MA; Internal Medicine, Hamad Medical Corporation, Doha, QAT.
  • Abu-Tineh M; Hematology, Hamad Medical Corporation, Doha, QAT.
  • Ahmed K; Hematology, Hamad Medical Corporation, Doha, QAT.
  • Alshurafa A; Hematology, Hamad Medical Corporation, Doha, QAT.
  • Rozi W; Internal Medicine, Hamad Medical Corporation, Doha, QAT.
  • Yassin MA; Hematology, Hamad General Hospital, Doha, QAT.
Cureus ; 14(5): e25196, 2022 May.
Article in English | MEDLINE | ID: covidwho-1897133
ABSTRACT
Coronavirus disease 2019 (COVID-19) is a respiratory viral illness caused by coronavirus 2 (SARS-CoV-2). The disease often presents with non-specific symptoms, including fever, and fatigue, usually associated with respiratory symptoms (eg., cough) and other systemic involvement. The primary strategy to prevent transmission and reduce the disease severity of the SARS-CoV-2 infection is through vaccination. However, the virus had shown significant changes and mutations that resulted in the emergence of different strains. Each strain varies in its virulence, disease severity, and the body's immune system response. Previous reports showed that the Omicron variant causes mild disease. Little is known about the effect of Omicron in patients with acute leukemia. We present three patients with acute leukemia who had an infection with the Omicron variant of the SARS-CoV-2 virus.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Topics: Vaccines / Variants Language: English Journal: Cureus Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Topics: Vaccines / Variants Language: English Journal: Cureus Year: 2022 Document Type: Article